Technology | Ultrasound Imaging | February 07, 2019

Philips Launches Epiq Elite Ultrasound Series

Series includes Obstetrics & Gynecology model with lifelike 3-D scans, General Imaging model with vascular assessment solution

Epiq Elite for Obstetrics and Gynecology delivers high image quality and lifelike 3-D scans

The Epiq Elite for Obstetrics & Gynecology. Image courtesy of Philips Healthcare.

The Philips Ultimate Ultrasound Solution for Vascular Assessment combines 3-D and 4-D imaging

The Epiq Elite for General Imaging with the Ultimate Ultrasound Solution for Vascular Assessment

February 7, 2019 — Philips announced the launch of the Epiq Elite ultrasound system, a new premium ultrasound that combines the latest advances in transducer innovation and enhanced performance to improve clinical confidence and the patient experience. Epiq Elite offers a range of diagnostic ultrasound solutions tailored to the needs of specific medical specialties, including Philips’ first solution for vascular assessment and diagnosis. In addition, Epiq Elite for Obstetrics & Gynecology delivers high image quality and lifelike 3-D scans to provide advanced fetal assessment during all stages of pregnancy.

The Philips Ultimate Ultrasound Solution for Vascular Assessment combines 3-D and 4-D imaging, a simplified workflow and complimentary clinical tools to effectively assess and monitor vascular disease. The xMatrix transducer can produce high-quality 3-D vascular images, allowing clinicians to easily see directly into a vessel to evaluate plaque spatial location and composition, as well as view 3-D flow data to quickly assess stenotic conditions. In addition, the solution includes live ‘xPlane’ imaging – proprietary to Philips – allowing clinicians to acquire two planes simultaneously to improve accuracy of data collection, and reduce exam time by 20 percent. Icon-driven visual workflow makes 3-D imaging easier, reducing the steps that the clinician needs to take from 10 to one. Bringing 3-D and 4-D visualization to vascular ultrasound for the first time, this solution provides an ideal communication tool to facilitate clinical decisions and enhance patient consultation.

“Not much has changed in vascular ultrasound until this release of the ultimate ultrasound solution for vascular assessment,” said Muhammad Hasan, MBBCh, RPVI, RVT, RDCS, RDMS, manager, Departments of Echocardiography and Noninvasive Vascular Testing, Miami Cardiac & Vascular Institute, Baptist Hospital of Miami. “The combination of a new transducer and advances in software makes the assessment and diagnosis of vascular conditions through easy to interpret images. There is now a case to be made for ultrasound solutions to be used as a potential alternative to other imaging modalities in the current standard of care.”

The ergonomic, lightweight V9-2 transducer is the first high-frequency PureWave transducer focused on getting fine detailed images as early as possible to help clinicians easily perform confident assessments of fetal health. Paired with TrueVue, the Epiq Elite system allows clinicians to manipulate a virtual light source around the 3-D images of the fetus, producing lifelike images that provide a high level of detail to enable the identification of any abnormalities early on in pregnancy. The Philips aBiometry Assist application uses anatomical intelligence to automate time spent gathering measurements, reducing exam time to allow clinicians to spend more time with mothers-to-be.

“The high-resolution images I’m able to acquire using the V9-2 and eL18-4 PureWave transducers give me the ability to quickly evaluate a baby’s early development. With exceptional 2-D and 3-D resolution and excellent depth penetration, I can make more confident fetal health assessments during each trimester,” said Luis F. Goncalves, M.D., from Phoenix Children’s Hospital.

The Epiq Elite for Obstetrics & Gynecology will be showcased at the upcoming Society of Maternal-Fetal Medicine (SMFM) conference, Feb. 13-15 in Las vegas. The Epiq Elite for General Imaging, including the Ultimate Ultrasound Solution for Vascular Assessment, will be showcased at the European Congress of Radiology (ECR), Feb. 28 – March 3 in Vienna, Austria.

For more information: www.usa.philips.com/healthcare

Related Content

The key trends Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | January 20, 2021 | By Melinda Taschetta-Millane and Dave Fornell
MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI.

MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI. Image courtesy of Exact Imaging

Feature | Prostate Cancer | January 20, 2021 | By Brian Wodlinger, Ph.D.
Historically when a patient had an elevated PSA (prostate specific antigen) test their urologist would take the next
According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was estimated to be $1.3 billion in 2020 and projected to reach $1.9 billion by 2025, at a compound annual growth rate (CAGR) of 7.4 percent over 2020-2025.

The ulrich CTmotion

Feature | Contrast Media Injectors | January 20, 2021 | By Melinda Taschetta-Millane
According to a new...
Previously approved by FDA in the USA, MyLab X8 expands the reach of the MyLab Ultrasound Product Line with a fully featured premium imaging solution, integrating the latest technologies and delivering superior image quality without compromising workflow or efficiency.
News | Ultrasound Imaging | January 20, 2021
January 20, 2021 — Esaote North America announces that the...
More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

Feature | Angiography | January 19, 2021 | By Bhvita Jani
January 19, 2021 – With the postponement of non-essential elective surgeries and medical procedures in 2020 to conser
Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound.

Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound. Image courtesy of UVA Health

News | Focused Ultrasound Therapy | January 08, 2021
January 8, 2021 — A scalpel-free alternative to brain surgery has the potential to benefit people with...
Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site. #AI #AIhealthcare #AIecho

Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

News | Artificial Intelligence | January 06, 2021
January 6, 2021 — The U.S.